Telstar will participate in FarmaForum 2022 (Madrid, 5-6 October 2022), the trade fair for the pharmaceutical, biotechnology, cosmetics and laboratory technology industries. As part of this event, Marcel Porta, manager of Telstar’s Consulting Division in Spain, will give a workshop entitled «Paperless Validation: a necessity in the optimization of the validation process», which will address the impact of new digital applications in the implementation and qualification with digital documents instead of traditional paper in the optimization of the life cycle of the validation and verification process and risk management. This workshop will take place on October 5 at 10h.
Validation is an essential process in pharmaceutical production as it provides documented evidence that a system or process complies with GMP/FDA regulatory requirements and guarantees the correct manufacture of products at the required level of quality and safety assurance. The life cycle of the validation of a pharmaceutical process involves a long, tedious and time-consuming process of editing, approval and execution that consumes huge amounts of paper, in addition to the subsequent management process of this documentation, its archiving and subsequent recovery, wasting human, economic and environmental resources. The use of database applications designed for electronic and digital management optimizes the entire validation life cycle. Telstar DiSQ has been designed to facilitate project management, promote standardization, guarantee traceability, ensure compliance with Data Integrity concepts, provide real-time information on the status of the different documents and enable electronic execution and automatic generation of queries and reports on the validation status.
Marcel Porta is manager of Telstar’s Consulting Division in Spain, which covers the areas of Commissioning and Qualification, Validation of Computerized Systems, Audits, Preclinical/Clinical Support and Quality Assurance. He holds a Master’s Degree in Industrial Engineering from the UPC (Polytechnic University of Catalonia), with PhD studies in the area of Environmental Radioactivity and a Master’s Degree in Biomedical Engineering from the UB (University of Barcelona). He worked for more than 10 years in the multinational pharmaceutical company Alcon, assuming different functions, from Validation Manager to representative of the Management in Quality issues. In 2013 he joined Telstar.
Telstar: stand D32 – E17
Telstar will also participate in FarmaForum 2022 as an exhibitor (Stand D32 – E17). Telstar is a leading global brand in aseptic process solutions. The company, which is part of the azbil Group, specializes in the development of projects of high technological complexity, from the design and production of integrated process equipment to the design, engineering, GxP consulting and construction of biotechnological and pharmaceutical production plants, critical facilities, clean rooms and R&D laboratories.